Keeler Thomas Management’s Pfizer PFE Stock Holding History

Keeler Thomas Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.49M	Buy	145,127 +10,959	+8%	+$287K	1.24%	17
2026 Q1	$3.77M	Buy	134,168 +17,134	+15%	+$456K	1.59%	13
2025 Q4	$2.91M	Buy	117,034 +14,899	+15%	+$376K	1.39%	17
2025 Q3	$2.6M	Buy	102,135 +2,778	+3%	+$68.6K	1.06%	24
2025 Q2	$2.41M	Buy	+99,357	New	+$2.32M	1.04%	20
2023 Q1	–	Sell	-50,369	Closed	-$2.58M	–	83
2022 Q4	$2.58M	Sell	50,369 -2,429	-5%	-$116K	1.3%	37
2022 Q3	$2.31M	Buy	+52,798	New	+$2.57M	1.17%	36
2021 Q1	–	Sell	-69,739	Closed	-$2.57M	–	83
2020 Q4	$2.57M	Sell	69,739 -14,205	-17%	-$521K	1.44%	30
2020 Q3	$2.91M	Buy	83,944 +8,757	+12%	+$307K	1.84%	25
2020 Q2	$2.39M	Buy	+75,187	New	+$2.55M	1.73%	25
2018 Q1	–	Sell	-1,897	Closed	-$65K	–	118
2017 Q4	$65K	Buy	+1,897	New	+$64.7K	0.06%	79

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Keeler Thomas Management's PFE Position: Q2 2026 in Review

Keeler Thomas Management increased its Pfizer (PFE) stake by 8.2% in Q2 2026, buying an estimated $287K and bringing the position to 145,127 shares worth $3.49M. The position accounts for 1.24% of the portfolio, ranked #17.

Keeler Thomas Management first reported a position in PFE in Q4 2017 and has held it in 11 quarters since. The position peaked at $3.77M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Keeler Thomas Management held 145,127 shares of Pfizer worth $3.49M as of Q2 2026.
Keeler Thomas Management bought 10,959 Pfizer shares in Q2 2026, an estimated $287K.
Pfizer made up 1.24% of Keeler Thomas Management's portfolio in Q2 2026, its #17 holding.
Keeler Thomas Management first reported a position in Pfizer in Q4 2017 and has held it in 11 quarters since.
Keeler Thomas Management's Pfizer position peaked at $3.77M in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Keeler Thomas Management's 13F filing for Q2 2026, filed 30 Jul 2026.